- Home
- GNPX vs SBFM Comparison
GNPX vs SBFM Comparison
Compare GNPX & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNPX
- SBFM
- Stock Information
- Founded
- GNPX 2009
- SBFM 2006
- Country
- GNPX United States
- SBFM United States
- Employees
- GNPX N/A
- SBFM N/A
- Industry
- GNPX Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- GNPX Health Care
- SBFM Health Care
- Exchange
- GNPX Nasdaq
- SBFM Nasdaq
- Market Cap
- GNPX 6.2M
- SBFM 4.9M
- IPO Year
- GNPX 2018
- SBFM N/A
- Fundamental
- Price
- GNPX $0.27
- SBFM $1.55
- Analyst Decision
- GNPX Strong Buy
- SBFM Strong Buy
- Analyst Count
- GNPX 1
- SBFM 1
- Target Price
- GNPX $10.00
- SBFM $15.00
- AVG Volume (30 Days)
- GNPX 7.3M
- SBFM 4.3M
- Earning Date
- GNPX 05-13-2025
- SBFM 05-19-2025
- Dividend Yield
- GNPX N/A
- SBFM N/A
- EPS Growth
- GNPX N/A
- SBFM N/A
- EPS
- GNPX N/A
- SBFM N/A
- Revenue
- GNPX N/A
- SBFM $34,874,283.00
- Revenue This Year
- GNPX N/A
- SBFM $192.48
- Revenue Next Year
- GNPX N/A
- SBFM N/A
- P/E Ratio
- GNPX N/A
- SBFM N/A
- Revenue Growth
- GNPX N/A
- SBFM 44.75
- 52 Week Low
- GNPX $0.22
- SBFM $1.17
- 52 Week High
- GNPX $4.09
- SBFM $33.60
- Technical
- Relative Strength Index (RSI)
- GNPX 44.92
- SBFM 44.81
- Support Level
- GNPX $0.23
- SBFM $1.17
- Resistance Level
- GNPX $0.44
- SBFM $1.59
- Average True Range (ATR)
- GNPX 0.04
- SBFM 0.19
- MACD
- GNPX 0.00
- SBFM 0.03
- Stochastic Oscillator
- GNPX 26.65
- SBFM 52.84
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.